Looking to publish in Antiviral Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowAntiviral Research publishes manuscripts on the prevention and treatment of viral diseases in humans and vertebrate animals, including antiviral drugs, antibodies, host-response modifiers, new drug targets, animal models, drug resistance, pathogenesis, safety assessments, and vaccines. It is the official publication of the International Society for Antiviral Research and publishes original research reports, short communications, commentaries, and invited review articles.
Looking to publish in Antiviral Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Antiviral Research accepts the following article types. Click on an article type to view submission instructions.
Research Articles
Review Articles
Short Communications
Commentaries
Recent Publications
Human cytomegalovirus terminase inhibitors letermovir, tomeglovir, and the halogenated benzimidazoles modify DNA cleavage/packaging to generate a super-genomic DNA species by cleavage site skipping
Amine Ourahmane, Desy K. Balalimbong, Anne Sauer, Jian Ben Wang, Ahmed Al Qaffas, Razia Moorad, Justin Landis, Dirk P. Dittmer, Stephen J. Dollery, Michael A. McVoy
Identification of Nsp15 inhibitors restoring interferon-dependent antiviral activity against SARS-CoV-2
Stefania Maloccu, Yuka Otsuka, Elizabeth Molchan, Michelle Foti, Annalaura Paulis, Jyoti Vishwakarma, Paolo Malune, Filippo Cottiglia, Angela Corona, Louis Scampavia, Timothy P. Spicer, Reuben S. Harris, Enzo Tramontano, Elisa Fanunza
West Nile Virus inhibits type I interferon response via TRIM71 in human microglial cells
Apoorva, Sunit K. Singh
Bemnifosbuvir and remdesivir inhibit tick-borne encephalitis virus infection in complementary in vitro and ex vivo disease models
Simone Leoni, Isabel Schultz-Pernice, Zuzana Krátka, Lucie Freiholz, Amal Fahmi, Teodora David, Antoinette Golomingi, Fabian Blank, Michaela Beránková, Milan Dejmek, Denis Grandgirard, Ronald Dijkman, Daniel Růžek, Luděk Eyer, Marco P. Alves, Stephen L. Leib
Targeting dengue virus envelope protein: Insights from structural analysis and high-throughput screening
Ruifang Wei, Edgar Jacoby, Emmanuel Gustin, Chloé Pluchart, Marnix Van Loock, Anil Koul, Doortje Borrenberghs, Olivia Goethals
Frequently asked questions
How long does it take to publish?
4 days submission to first decision; 33 days submission to decision after review; 81 days submission to acceptance; 2 days acceptance to online publication.
Reformat to Antiviral Research using Livewrite PremiumIs a cover letter required?
A cover letter is required with submission. It should be short, focused, explain the study's aim, main findings, fit with the journal's aims and scope, novelty, and broader implications, and should not include funding information, author declarations, or suggested or opposed reviewers.
Reformat to Antiviral Research using Livewrite PremiumWhat are the publication costs?
USD 3950 APC excluding taxes for open access articles; no open access publication fee for subscription publication.
Reformat to Antiviral Research using Livewrite Premium